Higher levels of inflammation linked to poorer survival rates are two to three times more likely in lung cancer patients with depression.
Medications commonly used to treat non-small cell lung cancer that has metastasized may have therapeutic benefits for patients with metastatic brain cancers.
Researchers discover key elements associated with tumor cells binding to blood vessels. The findings could help develop new treatments to halt the development of brain tumors.
Repurposing drugs used in the treatment of lung cancer could offer hope for symptom relief for patients suffering from chronic pain.
